Immuron (IMRN) Payables (2016 - 2025)

Immuron (IMRN) recorded quarterly Payables of $15294.3 in Q3 2025, down 97.63% quarter-over-quarter from $644701.1 in Q2 2025, and down 28.39% on a YoY basis from $21358.5 in Q3 2024.

Immuron (IMRN) Payables (2016 - 2025) Analysis & Trends

Immuron's Payables history runs 10 years deep, the most recent figure standing at $15294.3 for Q3 2025.

  • In Q3 2025, Payables fell 28.39% year-over-year to $15294.3; the TTM figure through Sep 2025 stood at $15294.3 (down 28.39% YoY), while the FY2025 annual figure was $15294.3, down 28.39% from the prior year.
  • Payables was $15294.3 for Q3 2025 at Immuron, down from $644701.1 in the prior quarter.
  • In the past five years, Payables ranged from a high of $842036.5 in Q4 2024 to a low of $10838.7 in Q4 2023.
  • Historically, Payables has averaged $506690.6 across 5 years, with a median of $614391.6 in 2025.
  • The sharpest annual moves came in 2021 and 2023: Payables jumped 23210.63% in 2021, then tumbled 98.58% in 2023.
  • A 5-year view of Payables shows it stood at $555231.3 in 2021, then soared by 37.37% to $762732.0 in 2022, then sank by 98.58% to $10838.7 in 2023, then surged by 7668.8% to $842036.5 in 2024, then plunged by 98.18% to $15294.3 in 2025.
  • The last three Payables figures came in at $15294.3 (Q3 2025), $644701.1 (Q2 2025), and $842036.5 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.05 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 300,549.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 83.00 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 8.69 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 489.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 34.55 Mn
10 Immuron 921.61 Mn 921.58 Mn - 15,294.34

Historic Data

Download Data
DateValue
Sep 2, 2025 15,294.34
Jun 30, 2025 644,701.05
Dec 31, 2024 842,036.48
Sep 9, 2024 21,358.52
Jun 30, 2024 427,608.70
Dec 31, 2023 10,838.70
Sep 28, 2023 781,835.96
Aug 30, 2023 11,927.69
Jun 30, 2023 797,199.62
Dec 31, 2022 762,732.01
Aug 31, 2022 807,311.55
Jun 30, 2022 831,510.88
Dec 31, 2021 555,231.32
Jun 30, 2021 584,082.20
Dec 31, 2020 2,381.88
Sep 1, 2020 384,397.00
Jun 30, 2020 251,941.72
Dec 31, 2019 3,843.97
Jun 30, 2019 764,858.99
Dec 31, 2018 689,326.00